A detailed history of Oak Harvest Investment Services transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oak Harvest Investment Services holds 104,779 shares of BMY stock, worth $6.16 Million. This represents 0.78% of its overall portfolio holdings.

Number of Shares
104,779
Holding current value
$6.16 Million
% of portfolio
0.78%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$39.66 - $51.75 $4.16 Million - $5.42 Million
104,779 New
104,779 $5.42 Million
Q2 2023

Jul 17, 2023

SELL
$63.71 - $70.74 $14,143 - $15,704
-222 Reduced 5.7%
3,674 $234,000
Q1 2023

Apr 20, 2023

SELL
$65.71 - $74.53 $43,105 - $48,891
-656 Reduced 14.41%
3,896 $270,000
Q4 2022

Jan 24, 2023

SELL
$68.48 - $81.09 $10,203 - $12,082
-149 Reduced 3.17%
4,552 $0
Q3 2022

Oct 14, 2022

SELL
$0.13 - $76.84 $6 - $4,072
-53 Reduced 1.11%
4,701 $334,000
Q2 2022

Jul 18, 2022

BUY
$72.62 - $79.98 $8,206 - $9,037
113 Added 2.43%
4,754 $366,000
Q1 2022

May 04, 2022

SELL
$61.48 - $73.72 $56,561 - $67,822
-920 Reduced 16.54%
4,641 $339,000
Q4 2021

Jan 21, 2022

BUY
$53.63 - $62.52 $9,170 - $10,690
171 Added 3.17%
5,561 $347,000
Q3 2021

Oct 08, 2021

SELL
$59.17 - $69.31 $37,040 - $43,388
-626 Reduced 10.41%
5,390 $319,000
Q2 2021

Jul 13, 2021

SELL
$61.91 - $67.42 $2.38 Million - $2.59 Million
-38,461 Reduced 86.47%
6,016 $402,000
Q1 2021

Apr 12, 2021

BUY
$59.34 - $66.74 $333,906 - $375,545
5,627 Added 14.48%
44,477 $2.81 Million
Q4 2020

Jan 15, 2021

BUY
$57.74 - $65.43 $2.24 Million - $2.54 Million
38,850 New
38,850 $2.41 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Oak Harvest Investment Services Portfolio

Follow Oak Harvest Investment Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Harvest Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on Oak Harvest Investment Services with notifications on news.